METROPOLITAN LIFE INSURANCE CO/NY - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$68,041
+46.8%
2,968
+5.6%
0.00%
+100.0%
Q2 2023$46,353
+32.5%
2,811
-7.4%
0.00%
+100.0%
Q1 2022$34,975
-53.5%
3,036
-59.7%
0.00%0.0%
Q4 2021$75,189
-34.5%
7,534
-14.3%
0.00%
-50.0%
Q3 2021$114,837
-52.9%
8,793
-29.4%
0.00%
-33.3%
Q2 2021$243,771
+19.2%
12,450
+29.5%
0.00%0.0%
Q1 2021$204,511
-31.9%
9,615
-4.8%
0.00%
-25.0%
Q4 2020$300,332
+37.2%
10,1020.0%0.00%0.0%
Q3 2020$218,910
-2.8%
10,1020.0%0.00%0.0%
Q2 2020$225,275
+46.5%
10,1020.0%0.00%
+33.3%
Q1 2020$153,752
-29.0%
10,102
+7.0%
0.00%
-25.0%
Q4 2019$216,674
+23.2%
9,437
+15.9%
0.00%
+33.3%
Q3 2019$175,829
+54.0%
8,144
+56.9%
0.00%
+50.0%
Q2 2019$114,202
-7.5%
5,191
+15.3%
0.00%0.0%
Q1 2019$123,400
-8.6%
4,502
-10.3%
0.00%
-33.3%
Q4 2018$134,938
+5.8%
5,020
+14.8%
0.00%
+50.0%
Q3 2018$127,560
-34.9%
4,373
-35.3%
0.00%
-33.3%
Q4 2017$196,0006,7570.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$9,074,0001.96%
NEA Management Company, LLC 4,912,306$49,025,0000.99%
RA Capital Management 4,871,067$48,613,0000.86%
Samsara BioCapital, LLC 345,293$3,446,0000.67%
Endurant Capital Management LP 197,462$1,971,0000.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,867,467$18,637,0000.39%
ACT CAPITAL MANAGEMENT, LLC 27,500$274,0000.20%
Baker Brothers Advisors 3,863,239$38,555,0000.19%
Rock Springs Capital Management LP 627,180$6,259,0000.14%
Aquatic Capital Management LLC 4,000$40,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders